Abstract
Recombinant adeno-associated virus (rAAV) vectors establish persistent transgene expression in the skeletal muscle of mice. How dendritic cells acquire encoded antigens for CD8 + T-cell priming is unknown. Here we document CD8 + T-cell priming after lethal irradiation and bone marrow reconstitution of mice treated with an AAV vector several weeks earlier. Temporal separation of vector delivery and successful class I antigen presentation indicated that T-cell priming does not necessarily require antigen synthesis in AAV-transduced dendritic cells. An apparent cross-presentation of antigen acquired from muscle suggests that strategies to limit transgene expression in dendritic cells will not prevent unwanted CD8 + T-cell responses.
| Original language | English |
|---|---|
| Pages (from-to) | 12083-12086 |
| Number of pages | 4 |
| Journal | Journal of virology |
| Volume | 85 |
| Issue number | 22 |
| DOIs |
|
| State | Published - Nov 2011 |
Fingerprint
Dive into the research topics of 'Continuous CD8 + T-cell priming by dendritic cell cross-presentation of persistent antigen following adeno-associated virus-mediated gene delivery'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver